IP Verse

Abbisko Therapeutics competitive analysis

Latest publications and patents of Abbisko Therapeutics New

Explore the latest publications and patents granted to Abbisko Therapeutics, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Abbisko Therapeutics
EP3632907	Feb 28, 2024	N-(Azaaryl)Cyclolactam-1-Carboxamide Derivative, Preparation Method Therefor, And Use Thereof	Granted And Under Opposition

Latest patents of Abbisko Therapeutics opposed by its competitors

Explore Abbisko Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP3632907	Feb 28, 2024	N-(Azaaryl)Cyclolactam-1-Carboxamide Derivative, Preparation Method Therefor, And Use Thereof	1

Latest PTAB cases involving Abbisko Therapeutics

Discover the latest PTAB cases involving Abbisko Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Abbisko Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
ABBISKO THERAPEUTICS	-	1	-	-	Non-Active
DECIPHERA PHARMACEUTICALS	1	2	-	-	Balanced